血管パッチの市場規模、シェア、成長分析：材料別、用途別、地域別 - 産業予測、2025年～2032年

血管パッチの市場規模は2023年に4億1,867万米ドルとなり、2024年の4億5,258万米ドルから2032年までには8億4,393万米ドルに拡大し、予測期間（2025年～2032年）のCAGRは8.10％で成長する見通しです。

慢性腎臓病（CKD）は、腎機能に徐々に影響を及ぼすため、糖尿病、高血圧、心血管疾患の重大なリスク要因として認識されつつあります。CKDの進行に伴い、身体は水分、電解質、老廃物の効率的な調整に苦慮し、危険な蓄積を招く可能性があります。国立糖尿病・消化器・腎臓病研究所の最近の統計によると、米国では3,700万人以上の成人がCKDに罹患していることが明らかになっており、CKDに対する認識と管理戦略の緊急の必要性が浮き彫りになっています。このような有病率の増加は、医療提供者や政策立案者にとって、患者の予後を改善し、合併症の負担を軽減するために、予防、早期発見、革新的な治療ソリューションに焦点を当てる大きなチャンスであることを示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要な市場の考察

• 主要成功要因
• 競合の程度
• 主要な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

血管パッチ市場規模：材料別・CAGR（2025年～2032年）

• 市場概要
• 生物学的血管パッチ
• 合成血管パッチ

血管パッチ市場規模：用途別・CAGR（2025年～2032年）

• 市場概要
• 頸動脈内膜切除術
• 腹部大動脈瘤の開腹修復術
• 血管バイパス手術
• 先天性心疾患
• その他の用途

血管パッチ市場規模：エンドユーザー別・CAGR（2025年～2032年）

• 市場概要
• 病院
• 外来手術センター

血管パッチ市場規模・CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022年～2024年）

主要企業プロファイル

• Baxter International Inc.（USA）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（USA）
• Getinge AB（Sweden）
• B. Braun SE（Germany）
• LeMaitre Vascular, Inc.（USA）
• W. L. Gore & Associates, Inc.（USA）
• Artivion, Inc.（formerly CryoLife, Inc.）（USA）
• Aziyo Biologics, Inc.（USA）
• Vascudyne, Inc.（USA）
• Collagen Solutions Plc（UK）
• FOC Medical S.A.（Switzerland）
• Obex Medical Ltd.（New Zealand）
• Vascumed（Pty）Ltd.（South Africa）
• Celox Medical（UK）
• Biom'up（France）
• Hemovent GmbH（Germany）
• Kuros Biosciences AG（Switzerland）
• Medtronic plc（Ireland）
• Abbott Laboratories（USA）

結論と提言

Vascular Patches Market size was valued at USD 418.67 Million in 2023 and is poised to grow from USD 452.58 Million in 2024 to USD 843.93 Million by 2032, growing at a CAGR of 8.10% during the forecast period (2025-2032).

Chronic kidney disease (CKD) is increasingly recognized as a significant risk factor for diabetes, hypertension, and cardiovascular diseases due to its gradual impact on kidney function. With the progression of CKD, the body struggles to regulate fluids, electrolytes, and waste effectively, which can result in dangerous buildups. Recent statistics from the National Institute of Diabetes and Digestive and Kidney Diseases reveal that more than 37 million adults in the United States are affected by CKD, highlighting the urgent need for awareness and management strategies. This growing prevalence indicates a considerable opportunity for healthcare providers and policymakers to focus on prevention, early detection, and innovative treatment solutions in order to improve patient outcomes and reduce the burden of associated comorbidities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The swift growth of the global elderly population is a major driver of the increasing prevalence of various health issues, including cardiovascular diseases, high cholesterol levels, hypertension, strokes, cancer, and aneurysms. Aging is a critical factor impacting cardiovascular health, and the rise in the elderly demographic significantly influences market growth in the vascular patches sector. As more individuals age, the demand for medical solutions addressing these age-related conditions surges, thereby stimulating advancements and investments in vascular patch technologies. This demographic trend underscores the urgent need for effective treatment options, further propelling the market forward.

Restraints in the Vascular Patches Market

The anticipated challenge to the growth of the Vascular Patches market during the forecast period is primarily linked to an increase in product recalls. For instance, Baxter International, a leading healthcare provider located in Illinois, recently initiated a recall of its Vascu-Guard peripheral vascular patch. Such recalls highlight prevailing quality and safety issues associated with certain medical products, which are expected to hinder the overall market's expansion. This particular incident underscores the significant effects that such events can have on market dynamics, potentially undermining consumer confidence and adversely affecting industry performance in the upcoming years.

Market Trends of the Vascular Patches Market

The vascular patches market is experiencing significant growth, driven by the rising adoption of minimally invasive procedures like MIDCAB (Minimally Invasive Direct Coronary Artery Bypass). This trend is fueled by a growing preference for safe, low-mortality interventions, alongside the compatibility of MIDCAB with cardiopulmonary bypass and aortic cross-clamping. As innovations in surgical techniques, including the use of coronary artery stent grafts, continue to evolve, they are expected to further stimulate demand for vascular grafts. Consequently, the market is poised for expansion, as healthcare providers increasingly prioritize advanced solutions that enhance patient outcomes and recovery times.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Vascular Patches Market Size by Material & CAGR (2025-2032)

• Market Overview
• Biologic Vascular Patches
• Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2025-2032)

• Market Overview
• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Other Applications

Global Vascular Patches Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2025-2032)

• North America (Material, Application, End User)
  • US
  • Canada
• Europe (Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc. (formerly CryoLife, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascudyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Solutions Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FOC Medical S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obex Medical Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascumed (Pty) Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celox Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations